SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-018777
Filing Date
2012-01-20
Accepted
2012-01-20 16:54:55
Documents
2
Period of Report
2012-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d284785d8k.htm 8-K 17004
2 FIRST AMENDMENT TO AT MARKET ISSUANCE SALES AGREEMENT d284785dex101.htm EX-10.1 9372
  Complete submission text file 0001193125-12-018777.txt   27525
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 12537577
SIC: 2834 Pharmaceutical Preparations